A protein interaction map identifies existing drugs targeting SARS-CoV-2

BACKGROUND: Severe acute respiratory syndrome coronavirus (SARS-CoV-2), an emerging Betacoronavirus, is the causative agent of COVID-19. Angiotensin converting enzyme 2 (ACE2), being the main cell receptor of SARS-CoV-2, plays a role in the entry of the virus into the cell. Currently, there are neit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cava, Claudia, Bertoli, Gloria, Castiglioni, Isabella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470683/
https://www.ncbi.nlm.nih.gov/pubmed/32883368
http://dx.doi.org/10.1186/s40360-020-00444-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470683/
https://www.ncbi.nlm.nih.gov/pubmed/32883368
http://dx.doi.org/10.1186/s40360-020-00444-z

Ejemplares similares